IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug?

Academic Article
Publication Date:
2018
CRIS type:
1.1 Articolo in rivista
Keywords:
bevacizumab; IFN-α; neuroendocrine tumors; randomized trials; targeted therapies; Oncology; Cancer Research
List of contributors:
Authors of the University:
Handle:
https://iris.unibs.it/handle/11379/507911
Published in:
FUTURE ONCOLOGY
Journal